Press Releases

Nov. 6, 2020- Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the following upcoming investor conferences: Peter Kuipers,...

GAAP and non-GAAP revenues of $213.7 million GAAP net income per diluted share of $0.20 Non-GAAP net income per diluted share of $0.60 Oct. 27, 2020- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence...

Represents Omnicell’s 142nd Long-Term Partnership with a Top 300 US Health System Oct. 22, 2020- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today...

Combination of automation and technology-enabled services supports more cost-effective workflows and expanded distribution models Oct. 20, 2020- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools...

The Industry-Leading Engagement and Digital Communication Solutions from EnlivenHealth Aim to Achieve Lifelong Optimal Health for Patient Populations Oct. 6, 2020- Omnicell, Inc., (NASDAQ:OMCL), a leading provider of medication management solutions...

Expands pharmacy inventory management capabilities for efficient, compliant management of 340B programs Accelerates Omnicell’s strategic transformation to support the vision of the fully Autonomous Pharmacy, building on the recent launch of Omnicell...

Sep. 29, 2020- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Tuesday, October 27, 2020 , to discuss the Company’s Third...

Sep. 23, 2020- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced today the pricing of $500 million aggregate principal amount of 0.25%...

Sep. 22, 2020- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced that it intends to offer, subject to market conditions and other factors,...

Sep. 1, 2020- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the following upcoming investor conferences: 2020 Wells Fargo Virtual...

Combination of technology, services, and data supports more cost-effective workflows Aug. 17, 2020- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today...

Expands pharmacy supply chain capabilities for efficient, compliant management of 340B programs Accelerates Omnicell’s strategic transformation to support the vision of the fully Autonomous Pharmacy, building on the recent launch of Omnicell One...

GAAP revenues of $199.6 million and net loss per diluted share of $0.10 Non-GAAP revenues $199.6 million and net income per diluted share of $0.37 Omnicell’s Response to Coronavirus (COVID-19) Jul. 28, 2020- Omnicell, Inc. (NASDAQ:OMCL), a leading...

Jul. 21, 2020- Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Tuesday, July 28, 2020 , to discuss the Company’s Second...

Omnicell One is a technology-enabled service leveraging cloud-based data and predictive, prescriptive analytics to improve clinical, financial and operational outcomes Jul. 20, 2020- Omnicell, Inc., (NASDAQ:OMCL), a leading provider of medication...

GAAP and non-GAAP revenues of $229.7 million, up 13.4% year-over-year GAAP net income per diluted share of $0.26, up 225.0% year-over-year Non-GAAP net income per diluted share of $0.66, up 8.2% year-over-year Omnicell’s Response to Coronavirus...